Melatonin in patients with reduced REM sleep duration: two randomized controlled trials
- PMID: 14715839
- DOI: 10.1210/jc.2002-021057
Melatonin in patients with reduced REM sleep duration: two randomized controlled trials
Abstract
Recent data suggest that melatonin may influence human physiology, including the sleep-wake cycle, in a time-dependent manner via the body's internal clock. Rapid-eye-movement (REM) sleep expression is strongly circadian modulated, and the impact of REM sleep on primary brain functions, metabolic processes, and immune system function has become increasingly clear over the past decade. In our study, we evaluated the effects of exogenous melatonin on disturbed REM sleep in humans. Fourteen consecutive outpatients (five women, nine men; mean age, 50 yr) with unselected neuropsychiatric sleep disorders and reduced REM sleep duration (25% or more below age norm according to diagnostic polysomnography) were included in two consecutive, randomized, double-blind, placebo-controlled, parallel design clinical trials. Patients received 3 mg melatonin daily, administered between 2200 and 2300 h for 4 wk. The results of the study show that melatonin was significantly more effective than placebo: patients on melatonin experienced significant increases in REM sleep percentage (baseline/melatonin, 14.7/17.8 vs. baseline/placebo, 14.3/12.0) and improvements in subjective measures of daytime dysfunction as well as clinical global impression score. Melatonin did not shift circadian phase or suppress temperature but did increase REM sleep continuity and promote decline in rectal temperature during sleep. These results were confirmed in patients who received melatonin in the second study (REM sleep percentage baseline/placebo/melatonin, 14.3/12.0/17.9). In patients who received melatonin in the first study and placebo in the second, the above mentioned effects outlasted the period of melatonin administration and diminished only slowly over time (REM sleep percentage baseline/melatonin/placebo, 14.7/17.8/16.2). Our findings show that exogenous melatonin, when administered at the appropriate time, seems to normalize circadian variation in human physiology. It may, therefore, have a strong impact on general health, especially in the elderly and in shift workers.
Similar articles
-
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.J Sleep Res. 2010 Dec;19(4):591-6. doi: 10.1111/j.1365-2869.2010.00848.x. J Sleep Res. 2010. PMID: 20561180 Clinical Trial.
-
The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects.J Biol Rhythms. 2003 Oct;18(5):420-9. doi: 10.1177/0748730403256796. J Biol Rhythms. 2003. PMID: 14582858 Clinical Trial.
-
Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.Sleep Med. 2007 Apr;8(3):222-39. doi: 10.1016/j.sleep.2006.09.006. Epub 2007 Mar 23. Sleep Med. 2007. PMID: 17368097
-
Chronobiotic protocol and circadian sleep propensity index: new tools for clinical routine and research on melatonin and sleep.Pharmacopsychiatry. 2004 Jul;37(4):139-46. doi: 10.1055/s-2004-827167. Pharmacopsychiatry. 2004. PMID: 15467968 Review.
-
[Sleep disturbances in the elderly: pathology, symptoms and treatment].Seishin Shinkeigaku Zasshi. 2010;112(8):709-19. Seishin Shinkeigaku Zasshi. 2010. PMID: 20976964 Review. Japanese.
Cited by
-
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease.Sleep Breath. 2022 Sep;26(3):1023-1031. doi: 10.1007/s11325-021-02417-w. Epub 2021 Aug 17. Sleep Breath. 2022. PMID: 34403081 Free PMC article. Clinical Trial.
-
The Effect of A Whey-Protein and Galacto-Oligosaccharides Based Product on Parameters of Sleep Quality, Stress, and Gut Microbiota in Apparently Healthy Adults with Moderate Sleep Disturbances: A Randomized Controlled Cross-Over Study.Nutrients. 2021 Jun 27;13(7):2204. doi: 10.3390/nu13072204. Nutrients. 2021. PMID: 34199006 Free PMC article. Clinical Trial.
-
Optogenetic sleep enhancement improves fear-associated memory processing following trauma exposure in rats.Sci Rep. 2020 Oct 22;10(1):18025. doi: 10.1038/s41598-020-75237-9. Sci Rep. 2020. PMID: 33093538 Free PMC article.
-
Neuromodulation of the Pineal Gland via Electrical Stimulation of Its Sympathetic Innervation Pathway.Front Neurosci. 2020 Apr 2;14:264. doi: 10.3389/fnins.2020.00264. eCollection 2020. Front Neurosci. 2020. PMID: 32300290 Free PMC article. Review.
-
Multilevel Interactions of Stress and Circadian System: Implications for Traumatic Stress.Front Psychiatry. 2020 Jan 28;10:1003. doi: 10.3389/fpsyt.2019.01003. eCollection 2019. Front Psychiatry. 2020. PMID: 32047446 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
